CNTA
Price
$13.70
Change
+$0.47 (+3.55%)
Updated
Apr 2 closing price
Capitalization
1.82B
46 days until earnings call
KYMR
Price
$26.36
Change
+$1.12 (+4.44%)
Updated
Apr 2 closing price
Capitalization
1.71B
28 days until earnings call
Ad is loading...

CNTA vs KYMR

Header iconCNTA vs KYMR Comparison
Open Charts CNTA vs KYMRBanner chart's image
Centessa Pharmaceuticals
Price$13.70
Change+$0.47 (+3.55%)
Volume$907.47K
Capitalization1.82B
Kymera Therapeutics
Price$26.36
Change+$1.12 (+4.44%)
Volume$717.33K
Capitalization1.71B
CNTA vs KYMR Comparison Chart
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. KYMR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a StrongBuy and KYMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CNTA: $13.70 vs. KYMR: $26.36)
Brand notoriety: CNTA and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 88% vs. KYMR: 116%
Market capitalization -- CNTA: $1.82B vs. KYMR: $1.71B
CNTA [@Biotechnology] is valued at $1.82B. KYMR’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than CNTA.

Price Growth

CNTA (@Biotechnology) experienced а -5.78% price change this week, while KYMR (@Biotechnology) price change was -13.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

CNTA is expected to report earnings on May 19, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($1.83B) has a higher market cap than KYMR($1.71B). CNTA YTD gains are higher at: -18.209 vs. KYMR (-34.477). CNTA has higher annual earnings (EBITDA): -147.19M vs. KYMR (-216.24M). CNTA has more cash in the bank: 518M vs. KYMR (489M). CNTA (84.7M) and KYMR (87.8M) have identical debt. KYMR has higher revenues than CNTA: KYMR (47.1M) vs CNTA (6.85M).
CNTAKYMRCNTA / KYMR
Capitalization1.83B1.71B107%
EBITDA-147.19M-216.24M68%
Gain YTD-18.209-34.47753%
P/E RatioN/AN/A-
Revenue6.85M47.1M15%
Total Cash518M489M106%
Total Debt84.7M87.8M96%
TECHNICAL ANALYSIS
Technical Analysis
CNTAKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCCNX66.72N/A
N/A
Fidelity Advisor Canada C
PMBJX40.86N/A
N/A
Principal MidCap J
SEMCX29.09N/A
N/A
SEI Mid-Cap F (SIMT)
QUAIX62.71N/A
N/A
AB Small Cap Growth I
TARZX23.29N/A
N/A
Third Avenue Real Estate Value Z

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with XENE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
+3.55%
XENE - CNTA
38%
Loosely correlated
+2.68%
ORIC - CNTA
37%
Loosely correlated
+4.52%
VCYT - CNTA
37%
Loosely correlated
+1.93%
KYMR - CNTA
37%
Loosely correlated
+4.46%
CRNX - CNTA
37%
Loosely correlated
+2.51%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+4.46%
CCCC - KYMR
59%
Loosely correlated
+5.92%
IMNM - KYMR
50%
Loosely correlated
+7.19%
NRIX - KYMR
50%
Loosely correlated
+8.69%
ATXS - KYMR
50%
Loosely correlated
+2.22%
ORIC - KYMR
48%
Loosely correlated
+4.52%
More